Role of Calcium Chloride Injection in Alleviating Atrial Fibrillation Post CABG

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.

Also called NCT06378021

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose prevention
Phase
Phase 3
Enrolled
  • 100 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06378021
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Egypt (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT06378021. Randomized; no masking; primary purpose prevention. Start 2024-03-14 (actual); primary completion 2025-03 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Role of Calcium Chloride Injection in Alleviating Atrial Fibrillation Post CABG
Intervention (Drug)
Calcium Chloride
Intervention (Drug)
Sodium Chloride 0.9% Inj
Lead sponsor
Helwan University (class: other)

Record details

Record id
cardio:ct-nct06378021
Content hash
f51dc0fabbee75cc89c5405cd5bcda574267e9a2393c1b746cfb5c9d40c79350